论文部分内容阅读
中新公司正在将经过十多年细胞分子水平研究筛选并经临床证明有明显疗效的中药复方制剂白龙片研制成抗癌新中成药。药效学实验证明,白龙片具有明显的溶杀癌细胞和提高机体免疫力的双重作用,并能缓解化疗产生的难以忍受的毒、副反应。毒理实验表明该药未见明显的毒、副作用,患者可长期服用。尤其对肝癌、肺癌患者效果更为显著,并且使用方便。该产品预计在1999年初正式投放市场,将成为企业发展的新的增长点。
Sino-Singapore is developing a Chinese medicine compound preparation Bailong Tablets, which has been screened for more than 10 years at the molecular level, and has been clinically proven to have significant curative effects, as a new anti-cancer medicine. Pharmacodynamic experiments have shown that Bailong Tablets have the dual functions of killing cancer cells and improving immunity, and can alleviate unbearable toxic and side effects caused by chemotherapy. Toxicological experiments showed that the drug had no obvious toxicity or side effects and patients could take it for a long time. Especially for liver cancer, lung cancer patients more effective, and easy to use. The product is expected to be put on the market in early 1999 and will become a new growth point for business development.